tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Australian Market
PAR
Paradigm Biopharmaceuticals Ltd.
Overview
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding AU:PAR?
Track your performance easily
Link Broker

Paradigm Biopharmaceuticals Ltd. (PAR) Stock News & Sentiment

23 Followers
Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing
Premium
Company Announcements
Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing
22h ago
Paradigm Biopharmaceuticals Announces ASX Quotation of Securities
Premium
Company Announcements
Paradigm Biopharmaceuticals Announces ASX Quotation of Securities
2d ago
Paradigm Biopharmaceuticals Strengthens Financial Position with R&D Tax Incentive
Premium
Company Announcements
Paradigm Biopharmaceuticals Strengthens Financial Position with R&D Tax Incentive
7d ago
Paradigm Biopharmaceuticals to Release Escrowed Securities from Employee Share Plan
Premium
Company Announcements
Paradigm Biopharmaceuticals to Release Escrowed Securities from Employee Share Plan
15d ago
Paradigm Biopharmaceuticals Updates on Director’s Securities
Premium
Company Announcements
Paradigm Biopharmaceuticals Updates on Director’s Securities
1M ago
Paradigm Biopharmaceuticals Issues New Performance Rights
Premium
Company Announcements
Paradigm Biopharmaceuticals Issues New Performance Rights
1M ago
Paradigm Biopharmaceuticals Issues New Shares Amid Drug Development Focus
Premium
Company Announcements
Paradigm Biopharmaceuticals Issues New Shares Amid Drug Development Focus
2M ago
More AU:PAR News >

PAR News on the Web

Paradigm Biopharmaceuticals Advances Phase 3 Trials with Strong Financial Backing
TipRanks News
Neutral
Phase III Trials: It#8217;s crunch time for these ASX health stocks
StockHead
Neutral
Paradigm Biopharmaceuticals Announces ASX Quotation of Securities
TipRanks News
Neutral
ASX Lunch Wrap: ASX edges up on Wall Street#8217;s record high, as Trump’s oil push stirs markets
StockHead
Neutral
Health Check: From feather duster to rooster, Nanosonics again rules the roost
StockHead
Neutral
Paradigm Biopharmaceuticals to Release Escrowed Securities from Employee Share Plan
TipRanks News
Neutral
Paradigm Biopharmaceuticals Updates on Director’s Securities
TipRanks News
Neutral
Paradigm Biopharmaceuticals Issues New Performance Rights
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
AU:PAR
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PAR’s Media Buzz Sentiment?
3 articles about AU:PAR were published this week. In an average week, 1.5 articles are published.
    What is AU:PAR’s weekly average amount of articles?
    In an average week, 1.5 articles about AU:PAR are published.
      What is AU:PAR’s News Sentiment?
      50% of articles about AU:PAR were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        LNTHLantheus
        INBSIntelligent Bio Solutions
        AKROAkero Therapeutics
        DVADaVita
        FNAParagon 28
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing